EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Blood Phenylalanine Levels in Patients with Phenylketonuria from Europe between 2012 and 2018: Is It a Changing Landscape?

Alex Pinto, Kirsten Ahring, Manuela Ferreira Almeida iD, Catherine Ashmore, Amaya Bélanger-Quintana iD, Alberto Burlina iD, Turgay Coşkun, Anne Daly iD, Esther van Dam, Ali Dursun, Sharon Evans iD, François Feillet und 17 weitere

Nutrients · 28.06.2024 · 16 (13) · 2064

DOI: 10.3390/nu16132064 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Nutrients, online erschienen am 28.06.2024. Verfasst von Alex Pinto und 28 weiteren Autor:innen. Beteiligte Einrichtung: Birmingham Children's Hospital, Birmingham B4 6NH, UK. Hauptthemen laut MEDLINE: Phenylketonurias, Phenylalanine. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BioMarin (United States), Biomarin independent research grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In 2011, a European phenylketonuria (PKU) survey reported that the blood phenylalanine (Phe) levels were well controlled in early life but deteriorated with age. Other studies have shown similar results across the globe. Different target blood Phe levels have been used throughout the years, and, in 2017, the European PKU guidelines defined new targets for blood Phe levels. This study aimed to evaluate blood Phe control in patients with PKU across Europe. Methods: nine centres managing PKU in Europe and Turkey participated. Data were collected retrospectively from medical and dietetic records between 2012 and 2018 on blood Phe levels, PKU severity, and medications.

Results

A total of 1323 patients (age range:1–57, 51% male) participated. Patient numbers ranged from 59 to 320 in each centre. The most common phenotype was classical PKU (n = 625, 48%), followed by mild PKU (n = 357, 27%) and hyperphenylalaninemia (HPA) (n = 325, 25%). The mean percentage of blood Phe levels within the target range ranged from 65 ± 54% to 88 ± 49% for all centres. The percentage of Phe levels within the target range declined with increasing age (41 years; 43% in females vs. 28% in males; p < 0.001). Patients treated with sapropterin (n = 222) had statistically significantly lower Phe levels compared to diet-only-treated patients (mean 391 ± 334 μmol/L; percentage within target 84 ± 39% vs. 406 ± 334 μmol/L; 73 ± 41%; p < 0.001), although a blood Phe mean difference of 15 µmol/L may not be clinically relevant. An increased frequency of blood Phe monitoring was associated with better metabolic control (p < 0.05). The mean blood Phe (% Phe levels within target) from blood Phe samples collected weekly was 271 ± 204 μmol/L, (81 ± 33%); for once every 2 weeks, it was 376 ± 262 μmol/L, (78 ± 42%); for once every 4 weeks, it was 426 ± 282 μmol/L, (71 ± 50%); and less than monthly samples, it was 534 ± 468 μmol/L, (70 ± 58%).

Conclusions

Overall, blood Phe control deteriorated with age. A higher frequency of blood sampling was associated with better blood Phe control with less variability. The severity of PKU and the available treatments and resources may impact the blood Phe control achieved by each treatment centre.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhenylketonuriasPhenylalanineHumansMaleAdolescentChildFemaleChild, PreschoolEuropeAdultYoung AdultRetrospective StudiesInfantMiddle AgedTurkey

Stichwörter der Autor:innen

classical PKUhyperphenylalaninaemiametabolic controlmild PKUmonitoringphenylalaninephenylketonuriasapropterintyrosine

Substanzen

Phenylalanine

Autor:innen und Institutionen

  • Birmingham Children's Hospital, Birmingham B4 6NH, UK.
  • School of Health Professions, Faculty of Health, University of Plymouth, Plymouth PL4 8AA, UK.
  • Departments of Paediatrics and Clinical Genetics, PKU Clinic, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark.
  • Centro de Genética Médica, Unidade Local de Saúde de Santo António, E.P.E. (ULSSA), 4099-028 Porto, Portugal.
  • Centro de Referência na área de Doenças Hereditárias do Metabolismo, Unidade Local de Saúde de Santo António, E.P.E. (ULSSA), 4099-001 Porto, Portugal.
  • Unit for Multidisciplinary Research in Biomedicine, Abel Salazar Institute of Biomedical Sciences, University of Porto-UMIB/ICBAS/UP, 4050-313 Porto, Portugal.

ORCID-Profile: Manuela Ferreira Almeida, Amaya Bélanger-Quintana, Alberto Burlina, Anne Daly, Sharon Evans, Mary Hickson, Alicja Leśniak, Michał Patalan, Júlio César Rocha, Francjan van Spronsen

Förderung

  • BioMarin (United States)
  • Biomarin independent research grant

Zitieren

APA

Pinto, A., Ahring, K., Almeida, M. F., Ashmore, C., Bélanger-Quintana, A., Burlina, A., Coşkun, T., Daly, A., van Dam, E., Dursun, A., Evans, S., Feillet, F., Giżewska, M., Gökmen-Özel, H., Hickson, M., Hoekstra, Y., Ilgaz, F., Jackson, R., Leśniak, A., …, & MacDonald, A. (2024). Blood Phenylalanine Levels in Patients with Phenylketonuria from Europe between 2012 and 2018: Is It a Changing Landscape?. Nutrients, 16(13), 2064. https://doi.org/10.3390/nu16132064

Vancouver

Pinto A, Ahring K, Almeida MF, Ashmore C, Bélanger-Quintana A, Burlina A, et al. Blood Phenylalanine Levels in Patients with Phenylketonuria from Europe between 2012 and 2018: Is It a Changing Landscape?. Nutrients. 2024;16(13):2064. doi:10.3390/nu16132064

BibTeX
@article{Pinto2024,
  author = {Pinto, Alex and Ahring, Kirsten and Almeida, Manuela Ferreira and Ashmore, Catherine and Bélanger-Quintana, Amaya and Burlina, Alberto and Coşkun, Turgay and Daly, Anne and van Dam, Esther and Dursun, Ali and Evans, Sharon and Feillet, François and Giżewska, Maria and Gökmen-Özel, Hulya and Hickson, Mary and Hoekstra, Yteke and Ilgaz, Fatma and Jackson, Richard and Leśniak, Alicja and Loro, Christian and Malicka, Katarzyna and Patalan, Michał and Rocha, Júlio César and Sivri, Serap and Rodenburg, Iris and van Spronsen, Francjan and Strączek, Kamilla and Tokatli, Ayşegül and MacDonald, Anita},
  title = {Blood Phenylalanine Levels in Patients with Phenylketonuria from Europe between 2012 and 2018: Is It a Changing Landscape?},
  journal = {Nutrients},
  year = {2024},
  volume = {16},
  number = {13},
  pages = {2064},
  doi = {10.3390/nu16132064}
}
Kostenlos starten →